2Petz LD, Garratty G, Calhoun L, et al. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion, 2000,40 (12) : 1446-1456.
3Goodnough LT, Kuter DJ, McCullough J, et al. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin. Blood, 2001, 98(5) :1346-1351.
4Kosugi S, Tomiyama Y, Honda S, et al. Platelet-associated anti-GP Ⅱb-Ⅲa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of glycoprotein (GP) Ⅱb. Blood, 2001,98(6):1819-1827.
5Boylan B, Chen H, Rathore V, et al. Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface. Blood, 2004,104(5): 1350-1355.
6Fabris F, Soini B, Sartori R, et al. Clinical and laboratory factors that affect the post transfusion platelet increment. Transfus Sci,2000,23(1) :63-68.
7Davoren A, Mcparland P, Crowley J, et al. Antenatal screening for human platelet antigen-la: results of a prospective study at a large maternity hospital in Ireland. BJOG,2003,110(5):492-496.
8Kekomaki S, Volin L, Koistinen P, et al. Successful treatment of platelet transfusion refractoriness : the use of platelet transfusions matched for both human leucocyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized patients with leukaemia. EurJ Haematol,1998,60(2):112-118.
9Killick SB, Win N, Marsh JC, et al. Pilot study of HLA alloimmunization after transfusion with pre-storage leucodepleted blood products in aplastic anaemia. Br J Haematol, 1997,97(3):667-684.
10Zhang X, Araki N, Ito K. Post-transfusion alloimmunization to granulocytes and platelets in Japanese patients as determined by the MPHA method. Transfus Apher Sci,2001,25(3):163-172.
